Ameriprise’s HUMANIGEN, INC. HGEN Stock Holding History

Ameriprise’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,320	Closed	-$61K	–	4073
2021 Q3	$61K	Buy	10,320 +20	+0.2%	+$281	﹤0.01%	3809
2021 Q2	$179K	Buy	+10,300	New	+$188K	﹤0.01%	3773

Other funds holding HGEN

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Ameriprise's HGEN Position: Q4 2021 in Review

Ameriprise sold out of HUMANIGEN, INC. (HGEN) in Q4 2021, closing a stake of 10,320 shares — an estimated $61K sold.

Ameriprise first reported a position in HGEN in Q2 2021 and held it in 2 quarters. The position peaked at $179K in Q2 2021. 89 funds tracked by Wall St. Rank hold HGEN as of Q4 2021.

Ameriprise reported no remaining HUMANIGEN, INC. position as of Q4 2021 after selling out during the quarter.
Ameriprise sold 10,320 HUMANIGEN, INC. shares in Q4 2021, an estimated $61K.
Ameriprise first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 2 quarters.
Ameriprise's HUMANIGEN, INC. position peaked at $179K in Q2 2021.
89 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2021.

Based on Ameriprise's 13F filing for Q4 2021, filed 14 Feb 2022.